Atlas Trials

Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis

Clinical trial NCT02317887 · COMPLETED

Trial details

NCT number
NCT02317887
Sponsor
VegaVect, Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
RetinoschisisX-Linked
Start date
2015-02-11
Primary completion
2024-04-25
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.